Poland· PL-100131176
Primovist
A gadoxetsäure product containing dinatrii gadoxetas, registered in Poland by Bayer AG. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Gadoxetsäure is registered in 12 of 19 countries.
Countries holding a registration under ATC V08CA10 (gadoxetsäure), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Gadoxetsäure · ATC V08CA10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Dinatrii gadoxetas
- Manufacturer
- Bayer AG
- Country
- Poland (PL)
- ATC code
- V08CA10
- ATC class
- Gadoxetsäure
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 15
- gtin05909990014231
- gtin05909990014248
- gtin05909990014255
- gtin05909990014262
- gtin05909990014279
- gtin05909990014293
- gtin05909990014309
- gtin05909990014330
- gtin05909990014347
- gtin05909991263645
- gtin05909991263652
- gtin05909991263669
- gtin05909991263676
- gtin05909991263683
- gtin05909991263690
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for gadoxetsäure.
Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadoxetsäure · interactions on record
34 records
- 34 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gadoxetsäure in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPRIMOVISTBayer AG, Leverkusen
- BelgiumPrimovist 0,25 mmol/mlBayer
- SwitzerlandPrimovist 0.25 mmol/ml, InjektionslösungBayer (Schweiz) AG
- FrancePRIMOVIST 0,25 mmol/mL, solution injectable en seringue préremplieBAYER HEALTHCARE
- NetherlandsPrimovist PFS 0,25 mmol/ml, oplossing voor injectie, voorgevulde spuitBayer B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e385bfd4-b716-46b6-a4a9-39ebe0d429de GET /v1/drugs/e385bfd4-b716-46b6-a4a9-39ebe0d429de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "0,25 mmol/ml",
"packaging": "05909990014231 ¦ Rp ¦ 25454\n1 amp.-strzyk. 5 ml\n05909990014248 ¦ Rp ¦ 25455\n5 amp.-strzyk. 5 ml\n05909990014255 ¦ Rp ¦ 25456\n10 amp.-strzyk. 5 ml\n05909990014262 ¦ Rp ¦ 25457\n1 amp.-strzyk. 7,5 ml\n05909990014279 ¦ Rp ¦ 25458\n5 amp.-strzyk. 7,5 ml\n05909990014293 ¦ Rp ¦ 25459\n10 amp.-strzyk. 7,5 ml\n05909990014309 ¦ Rp ¦ 25460\n1 amp.-strzyk. 10 ml\n05909990014330 ¦ Rp ¦ 25461\n5 amp.-strzyk. 10 ml\n05909990014347 ¦ Rp ¦ 25462\n10 amp.-strzyk. 10 ml\n05909991263645 ¦ Rp ¦ 114351\n1 amp.-strzyk. 10 ml\n05909991263652 ¦ Rp ¦ 114352\n1 amp.-strzyk. 5 ml\n05909991263669 ¦ Rp ¦ 114353\n5 amp.-strzyk. 5 ml\n05909991263676 ¦ Rp ¦ 114354\n5 amp.-strzyk. 10 ml\n05909991263683 ¦ Rp ¦ 114355\n10 amp.-strzyk. 5 ml\n05909991263690 ¦ Rp ¦ 114356\n10 amp.-strzyk. 10 ml",
"substance": "gadoksetynian disodowy 181.43 mg/ml",
"common_name": "Dinatrii gadoxetas",
"pl_product_id": "100131176",
"pozwolenie_nr": "11140",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about gadoxetsäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.